Flex is expanding in Poland as part of its global growth strategy to invest in essential power and data center technologies and sites to meet the growing customer demand. The new Polish site comes after opening a second facility in Dundalk, adding 120,000 square feet3, doubling Anord Mardix's capacity in Ireland. The Dundalk facility, named D2, assembles switchgear products to efficiently meet the rising global demand for reliable data center power, fueled by AI growth. Additionally, the company recently op ...

Core Insights - Nortech Systems Incorporated will hold a live conference call and webcast on May 14, 2025, at 3:30 p.m. Central Time to discuss its first quarter 2025 financial results [1] - The call will be hosted by the CEO Jay D. Miller and CFO Andrew D. C. LaFrence [1] Company Overview - Nortech Systems is a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products [2] - The company serves various markets including medical imaging, medical devices, aerospace & defense, and industrial sectors [2] - Nortech's design services cover the entire process from concept development to commercial design, including various engineering disciplines [2] - The company has vertically integrated manufacturing and supply chain capabilities, focusing on wire/cable/interconnect assemblies and printed circuit board assemblies [2] - Nortech is headquartered in Maple Grove, Minnesota, and operates six manufacturing locations and design centers across the U.S., Latin America, and Asia [2] - The company is publicly traded on the NASDAQ under the symbol NSYS [2]

Core Insights - Flex Ltd. reported strong fiscal full-year results, particularly highlighting significant growth in its data center segments, which has been positively received by the investing community [1]. Financial Performance - The company’s data center segments are experiencing rapid growth, contributing to overall positive fiscal results [1]. Investment Perspective - The results indicate a favorable outlook for long-term investors, especially those focused on a 5-10 year horizon, suggesting that Flex Ltd. may be a compelling option for a diversified portfolio that includes growth, value, and dividend-paying stocks [1].

Financial Data and Key Metrics Changes - Net sales for Q3 totaled $375 million, representing a 10% decline year over year when excluding the divested AT and M business [8][13] - Gross margin rate in Q3 was 7.2%, a 70 basis point decline compared to 7.9% in the same period last year [13] - Adjusted net income in Q3 was $6.8 million or $0.27 per diluted share, down from $9.8 million or $0.39 per diluted share in the same quarter last year [16] Business Line Data and Key Metrics Changes - Medical segment net sales were $115 million, up 2% year over year, driven by non-recurring consignment inventory sales [8][9] - Automotive segment net sales were $173 million, a 14% decrease year over year, with strong performance in China and Europe but a decline in North America [10][11] - Industrial segment net sales were $86 million, down 15% year over year, with declines across all regions [12] Market Data and Key Metrics Changes - Sales in the Medical market increased, while the Automotive and Industrial markets experienced declines [8][10][12] - The company noted strong sales in China for the automotive segment, with a modest increase in Europe [10] Company Strategy and Development Direction - The company is focusing on expanding its presence in the medical contract manufacturing organization (CMO) space, with a new facility in Indianapolis dedicated to this sector [6][9] - The strategy includes utilizing cash generated from EMS operations to invest in the CMO business, with expectations for organic revenue growth over time [7][9] - The company is also closing its Tampa facility to streamline operations and improve global capacity utilization [23] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about returning to growth through emerging medical technologies and high-level assemblies [23] - The current tariff environment presents uncertainty, impacting the timing of recovery in the core EMS business [21][22] - Management reiterated guidance for fiscal year 2025, expecting to be at the high end of sales and operating income ranges [19] Other Important Information - Cash and cash equivalents at the end of Q3 were $51.4 million, with operating cash flow of $30.9 million [16][18] - The company has reduced borrowings by 40% from the beginning of the fiscal year, indicating improved financial health [18] Q&A Session Summary Question: Details about the new facility in Indianapolis - The new facility provides more space and capabilities for medical CMO, with lease terms designed to minimize upfront costs [25][26] Question: Impact of the existing facility's sale - It is too early to determine the potential value of the existing facility, with a transition period of two to three years expected [31][32] Question: Trends in open orders or backlog - The greatest increase in backlog was seen in the medical vertical, followed by industrial and automotive [33] Question: Orders pulled into March due to tariffs - Management is uncertain if orders were pulled forward but acknowledges the possibility [37] Question: Outlook for operating expenses - SG&A expenses are expected to rise in FY 2026 as investments are needed for growth [42] Question: Impact of tariffs on gross margin - Tariffs are expected to pressure gross margins, but management is working to maintain them [65]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $6.4 billion, growing nearly 4% year over year [5][22] - Adjusted operating margin reached a record 6.2%, marking the second consecutive quarter above 6% [5][22] - Adjusted EPS for Q4 was $0.73, up 28% from the previous year [6][22] - For the full fiscal year, adjusted operating margins were 5.7%, with adjusted EPS reaching a record $2.65, up 23% [6][25] Business Line Data and Key Metrics Changes - In the Reliability segment, revenue was $2.9 billion, down 1.3%, with operating income at $180 million and a margin of 6.2% [23] - The Agility segment saw revenue of $3.5 billion, growing 8.2%, with operating income of $230 million and a margin of 6.6% [23] - Data center revenue grew approximately 50% year over year, reaching about $4.8 billion, driven by cloud and power solutions [12][14] Market Data and Key Metrics Changes - The company reported strong growth in key markets such as data centers, with cloud programs generating about $3.5 billion [12][14] - The power products segment generated approximately $1.3 billion in revenue [12] - The company expects data center revenue to grow around the mid-thirty percent level in the next fiscal year [14] Company Strategy and Development Direction - The company is executing its FlexForward strategy, focusing on higher value businesses and operational efficiency [8][9] - The EMS plus products plus services strategy aims to enhance vertical integration and customization [10][11] - The company is positioned to benefit from regionalization trends and has expanded its operational footprint in North America [17][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a 6% adjusted operating margin a year ahead of schedule, despite macroeconomic uncertainties [21][35] - The company is navigating tariff impacts and is well-positioned to support customers through regionalization [15][20] - Management highlighted the importance of operational excellence and efficiency in driving record-level operating margins [30] Other Important Information - The company generated over $1 billion in free cash flow, maintaining an 80% plus free cash flow conversion target [6][25] - Inventory levels were reduced significantly, with net inventory down 18% year on year [26] - The company repurchased approximately $1.3 billion of stock, representing about 9% of outstanding shares [28] Q&A Session Summary Question: What are the drivers for the strong margin guidance for fiscal 2026? - Management indicated that continued growth in cloud and data center products, along with service business growth, will drive favorable mix impacts [40][42] Question: What is the demand for capacity in the U.S. and Mexico? - Management noted strong customer interest in capacity, with ongoing conversations about increasing utilization and productivity [43][45] Question: Can you elaborate on the scale advantages in data centers? - Management highlighted the unique capability of integrating compute and power, which differentiates the company from competitors [49][51] Question: How does customer-sourced inventory impact revenues and margins? - Management confirmed that while customer-sourced inventory primarily affects cloud business, it positively impacts margins [64][66] Question: What are the expectations for inventory and working capital in fiscal 2026? - Management expects some improvement in inventory rates but emphasizes continued focus on managing days of inventory effectively [101][104]

Q4 FY25 Earnings Presentation Quarter End: March 31, 2025 Earnings Announcement: May 7, 2025 Risks and non-GAAP disclosures This presentation contains forward-looking statements within the meaning of U.S. securities laws, including statements related to our future financial results and our guidance for future financial performance (including expected revenues, operating income, margins and earnings per share). These forward-looking statements are based on current expectations, forecasts and assumptions invo ...

Financial Performance - Net sales for Q3 totaled $374.6 million, a 12% year-over-year decrease, or a 10% decrease excluding AT&M[24, 26] - Medical net sales in Q3 were $115 million, up 2% compared to last year, representing 31% of total company sales[13, 15] - Automotive net sales were $173 million, a 14% decrease compared to last year, representing 46% of total company sales[17, 20] - Industrial net sales were $86 million, down 15% year-over-year excluding AT&M, representing 23% of total company sales[21, 23] - Adjusted selling & administrative expense totaled $11.2 million, a 24% reduction compared to last year, representing 3.0% of sales[33] - Adjusted operating income was $15.7 million, or 4.2% of net sales[37] Strategic Initiatives - The company is reiterating fiscal year 2025 guidance, expecting sales and operating income to be at the high-end of the range[8, 53] - A new manufacturing facility in Indianapolis focused on the medical industry is being added to expand presence as a medical CMO[8, 16] - Borrowings were reduced by $116 million, or 40%, from the beginning of the fiscal year, with short-term liquidity available totaling $304.6 million[50] Other - The gross margin rate in Q3 was 7.2%, a 70 bps decline compared to last year[27, 29]

Jabil (JBL) 2025 Conference Summary Company Overview - Jabil is a US domiciled company with **$30 billion** in revenue and **50,000** employees [2][3] - The company is described as an engineering-led supply chain enabled manufacturing company, with **10,000 engineers** contributing to its operations [3][4] Key Industry Insights - Jabil operates in **30 countries**, manufacturing for top brands across various end markets including healthcare, intelligent infrastructure, semi cap, communications, and consumer products [4][8] - The company emphasizes the importance of supply chain management, especially in the context of tariffs and macroeconomic challenges [8][11] Strategic Priorities 1. **Margin and Free Cash Flow Accretion**: Focus on improving margins and generating free cash flow, with a history of share buybacks [7][8] 2. **Support for Customers Amid Tariffs**: Assisting clients in navigating tariff challenges, leveraging a long-standing presence in various countries [8][9] 3. **Investment in Capabilities**: Continuous investment in engineering, supply chain systems, and capability-based acquisitions [10][11] Competitive Advantages - Jabil's engineering-led approach differentiates it from competitors, allowing it to assist customers from concept to market [13][14] - The company employs a unique work cell model, assigning dedicated teams to individual customers, enhancing customer relationships [14][15] - Long-tenured management team with an average of **23 years** of experience among direct reports, fostering strong customer relationships [17][19] Tariff and Supply Chain Dynamics - The company notes that the **Trump administration's tariffs** have accelerated the regionalization of supply chains, with many companies hesitant to move production due to regulatory uncertainties [21][22] - **90%** of Jabil's business in Mexico is USMCA compliant, minimizing tariff impacts [23][24] Market Trends and Growth Areas - **Healthcare**: Strong demand for auto-injector pens and insulin pens, with plans to ramp up production in Europe [72][73] - **Intelligent Infrastructure**: Significant growth in data cloud infrastructure and semiconductor testing, with a **40% year-on-year** increase in guidance [32][33] - **EV and Automotive**: Despite short-term challenges, long-term growth is expected as EV penetration increases [80][82] - **Renewables**: Positioned well to benefit from supply chain consolidation and the Inflation Reduction Act, despite current low demand [84] Financial Guidance and Capital Allocation - Jabil projects **$1.2 billion** in free cash flow for the year, with **80%** allocated to share buybacks and **20%** for tuck-in acquisitions [88][89] - The company aims for a **6% operating margin**, with strategies in place to improve capacity utilization and cost optimization [41][45] Conclusion - Jabil's ability to assist companies in manufacturing and supply chain management is underappreciated, with a strong presence in North America and capabilities to support engineering and manufacturing locally [91][92]

Core Viewpoint - Celestica (CLS) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3][5]. - Institutional investors often adjust their valuations based on earnings estimates, leading to significant stock price movements when estimates are revised [3]. Celestica's Earnings Outlook - Celestica is projected to earn $5.05 per share for the fiscal year ending December 2025, reflecting a year-over-year increase of 30.2% [7]. - Over the past three months, the Zacks Consensus Estimate for Celestica has risen by 1.7%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - The upgrade of Celestica to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [9].

Celestica Inc. (CLS) has gained 98.8% over the past year compared with the industry’s growth of 36.4%. It has also outperformed peers like Flex Ltd. (FLEX) and Jabil Inc. (JBL) . Flex has gained 26.7% and Jabil is up 25.9% over this period.  Celestica boasts a diverse portfolio of products that are integral to AI (artificial intelligence) applications. With more than 25 years of experience in manufacturing backed by a simplified and optimized global network, it is committed to delivering next-generation, cl ...